Core Active Ingredients Available for Wholesale Export
UniCare Bio-Tech delivers multi-ton supply reliability across standardized active phytochemicals and precision fermented nutraceutical powders.
The Ergothioneine Paradigm: Molecular Precision & OCTN1 Target Specificity
L-(+)-Ergothioneine (EGT; 2-mercaptohistidine trimethylbetaine) represents a structurally unique, naturally occurring amino acid derivative distinguished by its singular thiol-thione tautomeric dynamic. Unlike classical antioxidants such as Glutathione, Resveratrol, or Ascorbic Acid, which exist predominantly in the highly oxidizable thiol (-SH) state at physiological pH, Ergothioneine exists almost exclusively in the chemically resilient thione tautomeric form. This conformation endows EGT with remarkable chemical resistance against auto-oxidation, enzymatic degradation, and thermal cleavage.
In human biology, Ergothioneine is not absorbed through passive intracellular diffusion. Instead, it relies upon a highly evolutionary conserved, specific transmembrane transport mechanism mediated by the SLC22A4 (OCTN1) organic cation transporter. Discovered by Prof. Dirk Gründemann, OCTN1 exhibits an affinity constant for Ergothioneine that is over 100-fold higher than for any other physiological substrate.
- Direct Mitochondrial Target Accumulation: Crosses mitochondrial membranes to scavenge singlet oxygen and ferryl radicals directly at the site of oxidative phosphorylation.
- Zero Pro-Oxidant Activity: Does not generate cytotoxic hydroxyl radicals in the presence of transition metal ions (Fe²⁺ or Cu²⁺), functioning as a safe biological metal chelator.
- Remarkable Half-Life: Displays tissue-retention kinetics exceeding 30 days in erythrocytes and central nervous system parenchyma, preventing cyclic redox depletion.
Ergothioneine Production Paradigms: The Synthetic Biology Leap
Evaluating commercial extraction, multi-step organic synthesis, and next-generation precision biological fermentation.
Generation I: Mushroom Fruiting Extraction
Early industry methods extracted EGT from mycelia or edible mushrooms (Pleurotus ostreatus, Hericium erinaceus). While natural, the process suffers from severe agricultural bottlenecks.
- Natural Abundance: Extremely low yield (0.05% – 0.15% dry basis).
- Cost Profile: Economically prohibitive for large-scale nutraceutical dosage.
- Batch Vulnerability: High variation in heavy metal absorption and pesticide drift.
- Color/Odor: Residual fungal odor, dark brown hue limiting cosmetic clarity.
Generation II: Multi-Step Chemical Synthesis
Chemical alkylation of histidine using hazardous sulfur-donating reagents (e.g., mercaptans, methanethiol, methyl iodide). Creates difficult-to-clear optical isomeric contaminants.
- Enantiomeric Integrity: Often yields racemic mixtures requiring costly resolution.
- Toxic Reagents: Carries severe risks of residual alkylating agents and halogen solvents.
- Regulatory Rejection: Synthetic EGT faces intense regulatory friction across EU & Japan.
- Environmental Impact: High E-factor and hazardous toxic chemical waste discharge.
Generation III: UniCare Precision Fermentation (Engineered Strains)
Our breakthrough biosimilar bioprocess: Metabolic pathway engineering in non-pathogenic, food-grade Corynebacterium glutamicum and Saccharomyces cerevisiae.
- Chiral Purity: 100% pure biologically active L-(+)-enantiomer guaranteed.
- Purity Floor: Consistently achieves ≥99.0% by HPLC without toxic solvents.
- Downstream DSP: Microfiltration, continuous nanofiltration, multi-pass recrystallization.
- Sustainable Carbon Base: Plant-derived glucose/sucrose feedstocks with minimal carbon footprint.
Industrial Scaling: Driving the Ergothioneine Commercial Transition
Historically, Ergothioneine was categorized alongside experimental peptide APIs, with pricing exceeding $20,000 to $30,000 per kilogram. This price barrier restricted EGT to sub-efficacious "fairy dusting" concentrations in luxury skincare, entirely locking out dietary supplement formulations.
Through UniCare's integrated Chinese manufacturing footprint, we have industrialized China Factory 4.0 automation across high-density cellular culture, continuous substrate micro-feeding, and automated dissolved oxygen (DO) feedback loops.
Enterprise Formulation Solutions: From Longevity Stacks to Epigenetic Skincare
Engineered for high solubility, thermal stability (up to 100°C across pH 3.0–9.0), and synergy across multiple consumer product verticals.
Longevity & Neuro-Vitality
Potent cellular shield against mitochondrial senescence, neurodegenerative decline, and cognitive aging. Crosses the blood-brain barrier via cerebral endothelial OCTN1 expression.
- Synergy Stacks: Pairs with NMN, Spermidine, CoQ10, and PQQ.
- Target Clinical Dose: 5mg – 30mg daily oral dose.
- Dosage Form: Hard capsules, dual-chamber liquids, sublingual tablets.
Dermo-Cosmetics & Photoprotection
Protects basal keratinocytes and dermal fibroblasts from UV-A induced mitochondrial DNA mutations and Matrix Metalloproteinase (MMP-1) collagen degradation.
- Cosmetic Benefits: Reverses photo-aging, inhibits tyrosinase activity.
- Formulation Compatibility: Completely clear in serums, odor-neutral.
- Usage Level: 0.1% to 2.0% w/w in emulsions and ampoules.
Functional Beverages & RTDs
Outstanding aqueous stability across broad pH windows (3.0 – 7.5). Survives severe pasteurization (HTST and UHT) without thermal degradation or off-notes.
- Key Applications: Energy drinks, cognitive shots, adaptogenic tonics.
- Organoleptic Status: Odorless, neutral crystalline white powder.
- Shelf Stability: Documented >24 months aqueous stability.
Biomedical & Clinical Nutrition
Investigated in clinical organ transplantation perfusion fluids and medical food formulations for post-ischemic reperfusion injury prevention.
- Redox Capacity: Protects cellular lipid bilayers from hydroperoxides.
- Quality Grade: Low-endotoxin pharmaceutical grade available.
- Regulatory: DMF documentation in preparation for clinical files.
Batch Release Specification Matrix: Pure L-Ergothioneine Powder
Every commercial production lot is subjected to chromatographic testing by in-house UHPLC/GC-MS/ICP-MS instrumentation prior to QA release.
| Analytical Parameter | Monograph Target Specification | Testing Methodology | Typical Factory Result | Status |
|---|---|---|---|---|
| Chemical Identity | Conforms to L-(+)-Ergothioneine reference standard | Chiral HPLC & ¹H-NMR / FT-IR | Matches standard spectrum | Conforms |
| Assay (Anhydrous Basis) | ≥ 99.0% w/w | HPLC-UV / DAD (254nm) | 99.6% – 99.9% | Conforms |
| Specific Optical Rotation | [α]D²⁰ = +122.0° to +128.0° | Polarimetry (c=1 in H₂O) | +125.4° | Conforms |
| Appearance & State | White to off-white crystalline fine powder | Visual & Organoleptic inspection | Pure White Crystal | Conforms |
| Chiral Optical Purity | ≥ 99.5% L-Enantiomer (D-isomer ≤ 0.5%) | Chiralpak CSP-HPLC Column | > 99.8% L-Form | Conforms |
| Heavy Metals (Pb, As, Cd, Hg) | Pb ≤ 0.5 ppm, As ≤ 0.5 ppm, Cd ≤ 0.2 ppm, Hg ≤ 0.1 ppm | ICP-MS (Agilent 7900) | < 0.05 ppm (ND) | Conforms |
| Residual Solvents (Class 1, 2, 3) | Meets USP <467> and Ph. Eur. limits (Zero Class 1) | Headspace GC-MS (Shimadzu) | Complies with EP / USP | Conforms |
| Loss on Drying / Moisture | ≤ 1.0% w/w | Karl Fischer Titration / Vacuum 105°C | 0.32% | Conforms |
| Total Aerobic Microbial Count | ≤ 1,000 CFU/g (TAMC), Yeast/Mold ≤ 100 CFU/g | USP <61> / Ph. Eur. 2.6.12 | < 50 CFU/g | Conforms |
| Specified Pathogens (E. coli, Salmonella) | Negative in 25g | USP <62> Membrane Filtration | Negative | Conforms |
Global Compliance: Regulatory Audits & Destination Assurance
Regulatory hurdles can disrupt overseas ingredient distribution. As an international supplier, UniCare Bio-Tech supports procurement teams with full regulatory validation across key destination jurisdictions:
United States (FDA GRAS)
Documented Generally Recognized As Safe (GRAS) toxicological dossier, including 90-day subchronic oral toxicity and genetic mutagenicity testing.
European Union (EFSA Novel Food)
Fully compliant with Commission Implementing Regulation (EU) 2017/2470 authorizing the placement of L-Ergothioneine as a novel food ingredient.
China (NMPA Cosmetic Notification)
Assigned standard cosmetic ingredient safety submission code for effortless filing on the National Medical Products Administration (NMPA) portal.
Australia & New Zealand (FSANZ / TGA)
Technical safety data sheets (MSDS/TDS), allergen-free declarations, and non-animal origin documentation for TGA listed medicines.
Integrated Nutraceutical & Standardized Botanical Supply Lines
Combine L-Ergothioneine with clinically authenticated botanical extracts for multi-target antioxidant, metabolic, and vitality formulations.
Enterprise Technical & Sourcing FAQ: Ergothioneine Powder
Addressing core supplier audit criteria, analytical validation methods, and global shipping parameters for international brands.
Which certifications do UniCare's manufacturing partners hold?
How are UniCare botanical and fermented extracts tested before release?
What documents are supplied with each batch of Ergothioneine?
Can UniCare customize ingredient specifications and particle sizes?
How can international buyers request an official catalog or testing samples?
What is the difference between synthetic Ergothioneine and fermented L-Ergothioneine?
What is the recommended storage stability and shelf-life of bulk Ergothioneine powder?
What are the minimum order quantity (MOQ) and commercial delivery lead times?
What is the Harmonized System (HS) tariff classification code for Ergothioneine?
High-Purity Phytochemical & Botanical Extracts for Global Delivery
In addition to pure Ergothioneine powder, UniCare Bio-Tech delivers bulk manufacturing capacity across our verified active botanical portfolio.
Initiate Supplier Qualification & Request Ergothioneine Samples
Connect with UniCare's pharmaceutical engineering team. Receive technical dossier packages, chiral purity chromatograms, and pilot batch samples within 24 business hours.